Stock Updates

A look at a High Market Cap Stock: CVS Health Corporation, CVS

CVS Health Corporation, CVS is in the exchange NYSE and its industry is Health Care Plans in the sector of Healthcare. Based in USA, CVS Health Corporation, CVS  has a market cap of 104682.62. Since its IPO date on the 12/17/1984, CVS Health Corporation, CVS performance year to date is 1.55%. Today CVS Health Corporation, CVS has gained -0.71%, with a current price of 97.3.

Ownership of the company is 0.20% for insider ownership while institutional ownership is 83.80%. The management of the company have seen the company have a payout ratio of 35.40%. Return of assets are at 5.20%, with return on investment at 9.40%.

In terms of debt levels and profit levels, CVS Health Corporation, CVS is seeing a long-term debt/equity of 0.74. While Total debt/equity is 0.82. With a profit margin of 2.90%, this is combined with a gross margin of 16.60%, and operating margin of 5.40%. CVS Health Corporation ability to meet debt levels, with a current ratio of 1.1, while the quick ratio is 0.6.

For the last year CVS Health Corporation, CVS has seen a EPS growth of 16.80%. A performance for the year of -2.54%. The 52-week high is -8.38%, and the 52-week low is 21.55%. The average volume for CVS Health Corporation, CVS is 1861017.

With a target price of 111.46, can CVS Health Corporation, CVS reach this target? Looking at the value indicators of CVS Health Corporation, CVS. CVS Health Corporation has a P/E of 22.55 and a forward P/E of 14.9. Perhaps the more useful indicator than P/E, is PEG which has a value of 1.55. CVS Health Corporation also has a P/S and a P/B of 0.63 and 3.02 respectively. For P/cash, CVS Health Corporation has a value of 86.73, while it is 20.22 for P/free cash flow.

At the current price of 97.3, CVS Health Corporation has a dividend yield of 1.73%. We see a return on equity of 13.20%.

Looking more long-term CVS Health Corporation, is projected to get an EPS growth for the next five years of 14.58%. In the short-term an EPS growth of 12.24% in the next year is forecasted. This is after a EPS growth of 16.80% for this year and for the last five years a 13.30% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment